Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

Lancet
Fabrice BarlesiBiomarkers France contributors

Abstract

The molecular profiling of patients with advanced non-small-cell lung cancer (NSCLC) for known oncogenic drivers is recommended during routine care. Nationally, however, the feasibility and effects on outcomes of this policy are unknown. We aimed to assess the characteristics, molecular profiles, and clinical outcomes of patients who were screened during a 1-year period by a nationwide programme funded by the French National Cancer Institute. This study included patients with advanced NSCLC, who were routinely screened for EGFR mutations, ALK rearrangements, as well as HER2 (ERBB2), KRAS, BRAF, and PIK3CA mutations by 28 certified regional genetics centres in France. Patients were assessed consecutively during a 1-year period from April, 2012, to April, 2013. We measured the frequency of molecular alterations in the six routinely screened genes, the turnaround time in obtaining molecular results, and patients' clinical outcomes. This study is registered with ClinicalTrials.gov, number NCT01700582. 18,679 molecular analyses of 17,664 patients with NSCLC were done (of patients with known data, median age was 64·5 years [range 18-98], 65% were men, 81% were smokers or former smokers, and 76% had adenocarcinoma). The median interva...Continue Reading

References

Sep 1, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Peter GoldstrawUNKNOWN Participating Institutions
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Sep 9, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher G AzzoliUNKNOWN American Society of Clinical Oncology
Nov 11, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L V SequistD Dias-Santagata
Nov 11, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Anne McLeer-FlorinSylvie Lantuejoul
Mar 17, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fabrice AndreFabien Calvo
Jul 11, 2012·Nature Reviews. Clinical Oncology·Frédérique NowakFabien Calvo
Jan 16, 2013·Cell Reports·Ludmil B AlexandrovMichael R Stratton
Jan 22, 2013·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Feb 13, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William D TravisGregory J Riely
Mar 26, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Petra MartinFrances A Shepherd
Apr 24, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julien MazièresOliver Gautschi
May 30, 2013·American Society of Clinical Oncology Educational Book·Frédérique NowakJean-Charles Soria
Jun 4, 2013·The New England Journal of Medicine·Alice T ShawPasi A Jänne
Aug 16, 2013·Nature·Ludmil B AlexandrovMichael R Stratton
Sep 5, 2013·JAMA : the Journal of the American Medical Association
Dec 18, 2013·Journal de gynécologie, obstétrique et biologie de la reproduction·P CrochetA Agostini
May 23, 2014·JAMA : the Journal of the American Medical Association·Mark G KrisPaul A Bunn
Aug 1, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Aug 15, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ReckUNKNOWN ESMO Guidelines Working Group

❮ Previous
Next ❯

Citations

Dec 15, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Michèle Beau-Faller, Jacques Cadranel
Jan 19, 2016·Lancet·Rafael Rosell, Niki Karachaliou
Apr 24, 2016·Clinical Lung Cancer·Mony UngJulien Mazières
May 2, 2016·Revue des maladies respiratoires·K AmraneG Quere
Jul 10, 2016·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jacques CadranelJie Zhang
Jun 5, 2016·Molecular Diagnosis & Therapy·Evgeny N ImyanitovSergey A Tjulandin
May 28, 2016·Expert Review of Clinical Pharmacology·Antonio Rossi
Jun 25, 2016·Genome Medicine·Charles AuffrayGianluigi Zanetti
Nov 8, 2016·Trends in Cancer·Jessica J Lin, Alice T Shaw
Sep 7, 2016·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Cécilia Gibelin, Sébastien Couraud
Sep 16, 2016·Lancet·Verena Schildgen, Oliver Schildgen
Sep 16, 2016·Lancet·Julien MazièresFabrice Barlesi
Sep 19, 2016·Revue des maladies respiratoires·L SakhriA-C Toffart
Oct 25, 2016·Bulletin du cancer·Etienne Giroux LeprieurMarie Wislez
Sep 21, 2016·Revue des maladies respiratoires·J CaliezC Chouaid
Oct 27, 2016·Future Oncology·Virginie Avrillon, Maurice Pérol
Oct 30, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Mercè Mateu-JimenezEsther Barreiro
May 27, 2016·PloS One·Geoffrey BrioudePascal-Alexandre Thomas
Dec 3, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sai-Hong Ignatius OuVamsidhar Velcheti
Jan 18, 2017·Journal of Controlled Release : Official Journal of the Controlled Release Society·Foyez MahmudYoungro Byun
Jan 10, 2017·Expert Opinion on Pharmacotherapy·Antonio RossiCesare Gridelli
Jan 22, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Nicolas PitonJean-Christophe Sabourin
Sep 25, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S NovelloUNKNOWN ESMO Guidelines Committee
Feb 2, 2017·International Journal of Molecular Sciences·Julie A VendrellJérôme Solassol
Dec 23, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sabine SchmidMartin Früh
Feb 13, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Nicolas GuibertJulien Mazières
May 4, 2017·Expert Review of Gastroenterology & Hepatology·Ashton A Connor, Steven Gallinger
Jun 22, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C R LindsayF Farace
Jul 15, 2017·Expert Opinion on Biological Therapy·Arnaud Jeanson, Fabrice Barlesi
Jul 12, 2017·Cancers·Ilija NenadićOliver Schildgen
Mar 1, 2018·Drugs·Jaquelyn N SanchezMark S Cohen
Jan 8, 2018·Clinical Chemistry and Laboratory Medicine : CCLM·Diane FrankelPatrice Roll
Apr 18, 2018·Journal of Cellular Biochemistry·Xiao-Jin WuDong-Sheng Pei
Jan 13, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N GuibertG R Oxnard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Related Papers

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Stephanie CardarellaB E Johnson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Ariel Lopez-ChavezGiuseppe Giaccone
Annals of Oncology : Official Journal of the European Society for Medical Oncology
S Zimmermann, S Peters
The European Respiratory Journal
Sébastien CouraudBioCAST/IFCT-1002 study investigators
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Claire TissotPierre-Jean Souquet
© 2022 Meta ULC. All rights reserved